Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| COG-AREN12B3 | Other Identifier | Children's Oncology Group | |
| CDR0000727229 | Other Identifier | Clinical Trials.gov | |
| AREN12B3 | Other Identifier | Children's Oncology Group | |
| NCI-2012-00689 | Registry Identifier | CTRP (Clinical Trial Reporting Program) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
RATIONALE: Studying samples of tissue from patients with rhabdoid tumors in the laboratory may help doctor learn more about changes that occur in DNA and identify genes related to cancer.
PURPOSE: This research trial studies biomarkers in samples from young patients with rhabdoid tumors.
OBJECTIVES:
OUTLINE: Freshly frozen rhabdoid tumors will be studied using fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) to establish the genomic location of transposons. Protein expression in rhabdoid tumor tissue microarrays is also analyzed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DNA analysis | Genetic | |||
| fluorescence in situ hybridization | Genetic | |||
| gene expression analysis | Genetic | |||
| gene mapping | Genetic | |||
| microarray analysis | Genetic | |||
| polymerase chain reaction | Genetic | |||
| protein expression analysis | Genetic |
| Measure | Description | Time Frame |
|---|---|---|
| Expression and function of transposons in rhabdoid tumors |
Not provided
Not provided
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Not provided
Not provided
Not provided
rhabdoid tumors
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elizabeth A. Mullen, MD | Dana-Farber Cancer Institute | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
| laboratory biomarker analysis | Other |
| medical chart review | Other |
| ID | Term |
|---|---|
| D007680 | Kidney Neoplasms |
| ID | Term |
|---|---|
| D014571 | Urologic Neoplasms |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052801 | Male Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D017404 | In Situ Hybridization, Fluorescence |
| D020869 | Gene Expression Profiling |
| D002874 | Chromosome Mapping |
| D046228 | Microarray Analysis |
| D016133 | Polymerase Chain Reaction |
| ID | Term |
|---|---|
| D017403 | In Situ Hybridization |
| D013194 | Staining and Labeling |
| D016591 | Histocytological Preparation Techniques |
| D003584 | Cytological Techniques |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D006652 | Histological Techniques |
| D008919 | Investigative Techniques |
| D020732 | Cytogenetic Analysis |
| D005821 | Genetic Techniques |
| D009693 | Nucleic Acid Hybridization |
| D046208 | Microchip Analytical Procedures |
| D021141 | Nucleic Acid Amplification Techniques |
Not provided
Not provided